UK's GW Pharma launches cannabis drug in Canada
Key points
- GW Pharmaceuticals Plc's pioneering cannabis-based medicine has been launched in Canada, the British firm said on Monday.
- GW said its Sativex medicine was now available by prescription in Canada to treat pain in adults with multiple sclerosis.
- GW's shares plunged earlier this month when the firm lost an appeal with UK regulators, meaning it will have to produce more data on Sativex before it is considered for approval in Britain.
GW Pharmaceuticals Plc's pioneering cannabis-based medicine has been launched in Canada, the British firm said on Monday.
GW said its Sativex medicine was now available by prescription in Canada to treat pain in adults with multiple sclerosis.
GW's shares plunged earlier this month when the firm lost an appeal with UK regulators, meaning it will have to produce more data on Sativex before it is considered for approval in Britain.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsAffymax, Takeda recall anemia drug Omontys after deaths
U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the U.S., due to reports of serious hypersensitivity reactions, including…
25 February 2013
NewsCannabis smokers more likely to develop testicular cancer
Cannabis smokers 'more likely to develop testicular cancer although risk can be reduced by using COCAINE' Men who smoke cannabis are at greater risk of testicular cancer, a new study suggests, but men who use cocaine…
11 September 2012
NewsTrying to quit smoking? Patches, drugs help: study
Trying to stop smoking? Smokers have considerably more success when they use nicotine patches or prescription medications than when they try to go it alone, an international study found. Past research has yielded…
5 September 2012
